Stent made from an ultra high molecular weight bioabsorbable polymer with high fatigue and fracture resistance

US9492587B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9492587-B2
Application numberUS-42278309-A
CountryUS
Kind codeB2
Filing dateApr 13, 2009
Priority dateApr 13, 2009
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stent made from an ultra high molecular weight bioabsorbable polymer is disclosed herein. The bioabsorbable polymer can have a Mw greater than 1 million g/mole or greater than 2 million g/mole. Methods of making the ultra high molecular weight polymer stent without degrading the molecular weight are further disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A stent comprising a scaffolding including a plurality of structural elements comprising: an abluminal layer and a luminal layer; wherein one of the layers is an ultra high molecular weight (UHMW) layer made from an UHMW bioabsorbable polymer having a weight average molecular weight greater than 1 million g/mole, and wherein the other layer is a low molecular weight (LMW) layer made from a LMW bioabsorbable polymer having a weight average molecular weight of between 50,000-300,000 g/mole. 2. The stent of claim 1 , wherein the UHMW bioabsorbable polymer and the LMW polymer are poly(L-lactide). 3. The stent of claim 1 , wherein a ratio of the thicknesses of the UHMW layer to the LMW layer is between 1000:1 and 2:1. 4. The stent of claim 1 , wherein the LMW layer includes a therapeutic substance dispersed within the LMW bioabsorbable polymer. 5. The stent of claim 1 , wherein sidewalls of the structural elements are free of material different from the UHMW layer and the LMW layer.

Assignees

Inventors

Classifications

  • Stent-grafts · CPC title

  • Joints · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

  • Coatings · CPC title

  • A61L31/06Primary

    obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9492587B2 cover?
A stent made from an ultra high molecular weight bioabsorbable polymer is disclosed herein. The bioabsorbable polymer can have a Mw greater than 1 million g/mole or greater than 2 million g/mole. Methods of making the ultra high molecular weight polymer stent without degrading the molecular weight are further disclosed.
Who is the assignee on this patent?
Kleiner Lothar W, Abbott Cardiovascular Systems Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).